Igor Dmitriev

Igor Dmitriev, PhD, serves as an Associate Professor of Radiation Oncology at Washington University School of Medicine in St. Louis. He joined the Cancer Biology Division in 2011 after previously working at the University of Alabama at Birmingham. Dr. Dmitriev's academic journey began at Novosibirsk State University where he earned his BS in Biology in 1983, followed by a PhD in Biological Sciences from the Institute of Molecular Biology SPA "VECTOR" in the Russian Federation in 1994.

Dr. Dmitriev's research primarily focuses on gene therapy and vaccine development, with particular expertise in engineering targeted adenoviral vectors for virotherapy treatment of cancer and prophylactic vaccine interventions. His publication history demonstrates consistent contributions to viral vector development, immunotherapy, and cancer treatment strategies. Recent work (2023-2025) centers on mucosal adenovirus vaccines, SARS-CoV-2 variants, and targeted gene delivery systems, reflecting his ongoing commitment to advancing viral vector technology for therapeutic applications.

His notable recognition includes the John R. Durant Award for Excellence in Cancer Research from the University of Alabama, Birmingham (1998), highlighting his longstanding contributions to cancer research. Dr. Dmitriev's collaborative work extends across multiple institutions, particularly with Dr. David T. Curiel's Gene Therapy Center, with whom he has maintained a long-standing research relationship since his post-doctoral training in 1996.